Old Republic International (NYSE:ORI) posted a significant jump in fourth-quarter net income, fueled by robust investment gains that offset a cooling in core underwriting profitability.
Procter & Gamble (NYSE:PG) maintained its full-year outlook Thursday despite a slight earnings dip, as the consumer giant leans into a massive $2 billion global restructuring to combat rising tariffs and a "bifurcated" consumer landscape.
Life Time Group Holdings (NYSE:LTH) today released preliminary fiscal 2025 results that showed a near-doubling of net income and introduced aggressive growth targets for 2026.
McCormick & Company (NYSE:MKC) today reported solid 2025 results and issued a robust 2026 outlook fueled by its recent acquisition of a controlling stake in McCormick de Mexico.
Atlantic Union Bankshares (NYSE:AUB) reported fourth-quarter adjusted operating earnings of $0.97 per share, handily beating the Wall Street consensus of $0.86.
TriCo Bancshares (NASDAQ:TCBK) reported fourth-quarter net income of $33.6 million, or $1.03 per diluted share.
The results represent a 15.8% increase over the $0.88 per share earned in the year-ago period, comfortably beating the analyst consensus of $1.01.
Amalgamated Financial Corp. (NASDAQ:AMAL) shares climbed Thursday after the mission-driven bank reported record quarterly deposit growth of nearly $1 billion, fueled by a massive influx of political and non-profit funds.
Commerce Bancshares (NASDAQ:CBSH) reported record quarterly revenue for the period ended Dec. 31, 2025, capping a year of significant expansion and robust capital growth.
The Kansas City-based lender posted fourth-quarter net income of $140.7 million, or $1.01 per diluted share, consistent with the previous quarter and up from $0.96 per share a year ago.
Texas Capital Bancshares (NASDAQ:TCBI) shares are set to test new highs after the Dallas-based lender reported fourth-quarter earnings that significantly outpaced Wall Street estimates, bolstered by a fresh share repurchase authorization.
Greenwich LifeSciences (NASDAQ:GLSI) shares jumped Thursday morning after the clinical-stage biotech announced that the U.S. Food and Drug Administration (FDA) has approved the use of its first commercially manufactured lot of GP2 vials in the ongoing FLAMINGO-01 Phase III trial.
ACM Research (NASDAQ:ACMR) issued a bullish 2026 outlook Thursday, signaling a significant revenue step-up as the semiconductor equipment maker scales its proprietary cleaning and furnace technologies.
Amentum (NYSE:AMTM) on Thursday announced its NEXUS-NL consortium has secured a landmark €180 million ($207 million) contract to spearhead the Netherlands' return to large-scale nuclear power.
